Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer
- 15 December 1995
- Vol. 76 (12) , 2457-2463
- https://doi.org/10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abnormalp53Expression in Human Lung Cancer is Associated with Histologic Subtypes and Patient Smoking HistoryAmerican Journal of Clinical Pathology, 1994
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Journal of Clinical Investigation, 1994
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- The relationship of p53 immunostaining to survival in carcinoma of the lungBritish Journal of Cancer, 1992
- Prognostic significance of the expression ofras oncogene product in non-small cell lung cancerCancer, 1992
- p53 Mutations in Human CancersScience, 1991
- K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungNew England Journal of Medicine, 1990
- ras oncogenes: their role in neoplasiaEuropean Journal of Clinical Investigation, 1990
- A genetic model for colorectal tumorigenesisCell, 1990
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989